CIHR-JDRF Type 1 Diabetes Screening Research Consortium funding opportunity

The figure below is related to the CIHR-JDRF Type 1 Diabetes Screening Research Consortium funding opportunity:

Figure 1: Consortium structure model

Long description

The Consortium structure model includes: 

  1. a leadership and governance group, made up of the nominated principal applicant and principal applicant of each research team, cross-cutting theme leads and at least one person with lived experience;
  2. a coordination core, that serves as an administrative hub that will facilitate engagement among T1D stakeholders to accelerate research, build synergies among Research Teams/Cross-Cutting Theme Leads, and mobilize knowledge generated to maximize the impact of the Consortium’s activities;
  3. six cross-cutting themes, including patient and citizen engagement, stakeholder engagement and knowledge mobilization, data and biosample governance, indigenous peoples, health disparities and equity, diversity and inclusion (EDI), and sex- and gender-based analysis+ (SGBA+), that will have a designated lead and be incorporated across the Consortium; and
  4. three or more research teams that will undertake research projects to address different aspects of T1D screening including acceptability, feasibility, and follow-up and clinical monitoring.
Date modified: